Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,074 public trials 1,853 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

NCT04407143

Conditions
COVID, COVID-19, Corona Virus Infection, +17 more
Locations
  • Complejo Hospitalario de A Coruña A Coruña, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
  • ICO Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
View all 68 locations
View Trial Details
Completed

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT04384146

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Completed

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

NCT05577702

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Guangzhou Medical Universitydatansha Hospital) Guangzhou, Guangdong, China
View all 14 locations
View Trial Details
Completed

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

NCT02917993

Conditions
Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • University of California San Diego, 3855 Health Sciences Drive, Mc 0987 La Jolla, California, United States
  • University California San Francisco Thoracic Surgery and Oncology Clinic, 1600 Divisadero Street, Floor 4 San Francisco, California, United States
  • Innovative Clinical Research Institute, 15111 Whittier Blvd., Suite 216 Whittier, California, United States
  • Rocky Mountain Cancer Center, 1800 Williams Street, Suite 200 Denver, Colorado, United States
View all 31 locations
View Trial Details

Related conditions